132 related articles for article (PubMed ID: 21046444)
1. Are elevated levels of IGF-1 caused by coronary arteriesoclerosis?: Molecular and clinical analysis.
Burchardt P; Gozdzicka-Jozefiak A; Zurawski J; Nowak W; Durzynska J; Link R; Grotowski T; Siminiak T
Protein J; 2010 Nov; 29(8):538-44. PubMed ID: 21046444
[TBL] [Abstract][Full Text] [Related]
2. Presence of irregularity in region between -1115 and -784 nt in P1 promoter of insulin-like growth factor-1 gene may indicate beneficial effect on coronary arteries in a group of patients with stable angina: preliminary data.
Burchardt P; Nowak W; Gozdzicka-Jozefiak A; Link R; Grotowski T; Wisniecka A; Siminiak T
Heart Vessels; 2009 Jul; 24(4):254-9. PubMed ID: 19626396
[TBL] [Abstract][Full Text] [Related]
3. The estimation of GC repeats in promoter P1 of IGF-1 gene and their influence on IGF-1 plasma levels in stable angina patients.
Burchardt P; Nowak W; Zurawski J; Gozdzicka-Jozefiak A; Siminiak T
Protein J; 2010 Oct; 29(7):524-9. PubMed ID: 20872173
[TBL] [Abstract][Full Text] [Related]
4. The association of functional polymorphisms in genes encoding growth factors for endothelial cells and smooth muscle cells with the severity of coronary artery disease.
Osadnik T; Strzelczyk JK; Lekston A; Reguła R; Bujak K; Fronczek M; Gawlita M; Gonera M; Wasilewski J; Szyguła-Jurkiewicz B; Gierlotka M; Gąsior M
BMC Cardiovasc Disord; 2016 Nov; 16(1):218. PubMed ID: 27835972
[TBL] [Abstract][Full Text] [Related]
5. The association of insulin-like growth factor-1 with severity of coronary artery disease.
Yousefzadeh G; Masoomi M; Emadzadeh A; Shahesmaeili A; Sheikhvatan M
J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):416-20. PubMed ID: 23160066
[TBL] [Abstract][Full Text] [Related]
6. Microsatellite polymorphism in the P1 promoter region of the IGF‑1 gene is associated with endometrial cancer.
Kwasniewski W; Gozdzicka-Jozefiak A; Wolun-Cholewa M; Polak G; Sierocinska-Sawa J; Kwasniewska A; Kotarski J
Mol Med Rep; 2016 Jun; 13(6):4950-8. PubMed ID: 27121258
[TBL] [Abstract][Full Text] [Related]
7. Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density.
Biong M; Gram IT; Brill I; Johansen F; Solvang HK; Alnaes GI; Fagerheim T; Bremnes Y; Chanock SJ; Burdett L; Yeager M; Ursin G; Kristensen VN
BMC Med Genomics; 2010 Mar; 3():9. PubMed ID: 20302654
[TBL] [Abstract][Full Text] [Related]
8. Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatment.
Ruotolo G; Båvenholm P; Brismar K; Eféndic S; Ericsson CG; de Faire U; Nilsson J; Hamsten A
J Am Coll Cardiol; 2000 Mar; 35(3):647-54. PubMed ID: 10716467
[TBL] [Abstract][Full Text] [Related]
9. Association between insulin like growth factor-1 and lipoprotein metabolism in stable angina patients on statin therapy: a pilot study.
Burchardt P; Tabaczewski P; Goździcka-Józefiak A; Siminiak T; Szczepaniak A; Banaszak A; Wysocki H
Kardiol Pol; 2012; 70(10):1017-22. PubMed ID: 23080092
[TBL] [Abstract][Full Text] [Related]
10. Influence of polymorphisms in genes encoding for insulin-like growth factor (IGF)-I, insulin, and IGF-binding protein (IGFBP)-3 on IGF-I, IGF-II, and IGFBP-3 levels in umbilical cord plasma.
Landmann E; Kollerits B; Kreuder JG; Blum WF; Kronenberg F; Rudloff S
Horm Res Paediatr; 2012; 77(6):341-50. PubMed ID: 22739332
[TBL] [Abstract][Full Text] [Related]
11. Impact of IGF-1, IGF-1R, and IGFBP-3 promoter methylation on the risk and prognosis of esophageal carcinoma.
Ye P; Qu CF; Hu XL
Tumour Biol; 2016 May; 37(5):6893-904. PubMed ID: 26662570
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the P1 promoter of the IGF-1 gene in children with growth disorders.
Broniarczyk JK; Kędzia A; Nowak W; Kościński Ł; Lewandowski M; Goździcka-Józefiak A
Pediatr Endocrinol Diabetes Metab; 2015; 20(4):136-42. PubMed ID: 26615580
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal study of insulin-like growth factor, insulin-like growth factor binding protein-3, and their polymorphisms: risk of neoplastic progression in Barrett's esophagus.
Siahpush SH; Vaughan TL; Lampe JN; Freeman R; Lewis S; Odze RD; Blount PL; Ayub K; Rabinovitch PS; Reid BJ; Chen C
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2387-95. PubMed ID: 18006928
[TBL] [Abstract][Full Text] [Related]
14. The impact of IGF-I gene polymorphisms on coronary artery disease susceptibility.
Lin HL; Ueng KC; Wang HL; Chen TP; Yang SF; Chu SC; Hsieh YS
J Clin Lab Anal; 2013 Mar; 27(2):162-9. PubMed ID: 23423640
[TBL] [Abstract][Full Text] [Related]
15. The Effect of GHR/exon-3 Polymorphism and Serum GH, IGF-1 and IGFBP-3 Levels in Diabetes and Coronary Heart Disease.
Kucukhuseyin O; Toptas B; Timirci-Kahraman O; Isbir S; Karsidag K; Isbir T
In Vivo; 2015; 29(3):371-8. PubMed ID: 25977383
[TBL] [Abstract][Full Text] [Related]
16. Associations among IGF-1, IGF2, IGF-1R, IGF-2R, IGFBP-3, insulin genetic polymorphisms and central precocious puberty in girls.
Chang HP; Yang SF; Wang SL; Su PH
BMC Endocr Disord; 2018 Sep; 18(1):66. PubMed ID: 30249230
[TBL] [Abstract][Full Text] [Related]
17. Association of the IGF-I promoter P1 polymorphism with risk of cervical cancer.
Pacholska-Bogalska J; Józefiak A; Nowak W; Kedzia W; Kwaśniewska A; Goździcka-Józefiak A
Eur J Gynaecol Oncol; 2011; 32(4):393-8. PubMed ID: 21941959
[TBL] [Abstract][Full Text] [Related]
18. Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women.
Jernström H; Deal C; Wilkin F; Chu W; Tao Y; Majeed N; Hudson T; Narod SA; Pollak M
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):377-84. PubMed ID: 11319179
[TBL] [Abstract][Full Text] [Related]
19. Association of the (CA)n repeat polymorphism of insulin-like growth factor-I and -202 A/C IGF-binding protein-3 promoter polymorphism with adult height in patients with severe growth hormone deficiency.
Miletta MC; Scheidegger UA; Giordano M; Bozzola M; Pagani S; Bona G; Dattani M; Hindmarsh PC; Petkovic V; Oser-Meier M; Flück CE; Mullis PE
Clin Endocrinol (Oxf); 2012 May; 76(5):683-90. PubMed ID: 22026507
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor.
Chen C; Freeman R; Voigt LF; Fitzpatrick A; Plymate SR; Weiss NS
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2461-6. PubMed ID: 17164371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
